Abstract
Nasopharyngeal carcinoma (NPC) is ranked 6th of malignant tumors in Indonesia. To analyze the correlation of dose and duration of cisplatin exposure with cytotoxic effects on nasopharyngeal carcinoma stem cells. The biopsy NPC tissue was cultured and processed to obtain NPC stem cells to be treated with cisplatin different doses and durations (24 and 48 h). The number of dead cells after exposure will be calculated using a hemocytometer. Death stem cell density of NPC at exposure of 2 μg/ml cisplatin dose was 81.37%, while the smallest death cell density a dose of 0.05 μg/ml after a 72-h observation was 21.3%. The coefficient correlation 0.827 and value p = 0.000 (p < 0.05). The analysis of the correlation between cisplatin exposure duration and death cell was also significant with the correlation coefficient − 0.357 and the value p = 0.001 (p < 0.05). There was a correlation between the increased dose of cisplatin with the cytotoxicity effects on NPC stem cell.
Similar content being viewed by others
References
Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo S et al (2012) Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer 31(4):185–196
Roezin A, Syafril A (2006) Buku ajar Ilmu Penyakit Telinga Hidung Tenggorok. Edisi kelima. Jakarta, FKUI
Longo-Sorbello G, Saydam G, Banerjee D, Bertino J (2006) Cytotoxicity and cell growth assays. In: Celis J, Charter N, Simons K, Small J, Hunter T, Shotton D (eds) Cell biology, four-volume set: a laboratory handbook, vol 1, 3rd edn. Academic Press, Amsterdam, pp 315–324
Jamieson ER, Lippard SJ (1999) Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99(9):2467–2498
Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Perez JM (2007) Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 7(1):3–18
Chan AT, Teo PM, Leung TW, Leung SF, Lee WY, Yeo W et al (1995) A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 33(3):569–577
Ma J, Mai HQ, Hong MH, Min HQ, Mao ZD, Cui NJ et al (2001) Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol Off J Am Soc Clin Oncol 19(5):1350–1357
Monroe MM, Anderson EC, Clayburgh DR, Wong MH (2011) Cancer stem cells in head and neck squamous cell carcinoma. J Oncol 2011:762780
Shafee N, Smith CR, Wei S, Kim Y, Mills GB, Hortobagyi GN et al (2008) Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors. Can Res 68(9):3243–3250
Troger V, Fischel JL, Formento P, Gioanni J, Milano G (1992) Effects of prolonged exposure to cisplatin on cytotoxicity and intracellular drug concentration. Eur J Cancer 28(1):82–86
Pisano C, Pratesi G, Laccabue D, Zunino F, Lo Giudice P, Bellucci A et al (2003) Paclitaxel and cisplatin-induced neurotoxicity: a protective role of acetyl-l-carnitine. Clin Cancer Res Off J Am Assoc Cancer Res 9(15):5756–5767
Wu YJ, Muldoon LL, Neuwelt EA (2005) The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J Pharmacol Exp Ther 312(2):424–431
Hong JY, Kim GH, Kim JW, Kwon SS, Sato EF, Cho KH et al (2012) Computational modeling of apoptotic signaling pathways induced by cisplatin. BMC Syst Biol 6:122
Hanigan MH, Deng M, Zhang L, Taylor PT Jr, Lapus MG (2005) Stress response inhibits the nephrotoxicity of cisplatin. Am J Physiol Renal Physiol 288(1):F125–F132
Saris CP, van de Vaart PJ, Rietbroek RC, Blommaert FA (1996) In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells. Carcinogenesis 17(12):2763–2769
Fanning J, Biddle WC, Goldrosen M, Crickard K, Crickard U, Piver MS et al (1990) Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assay. Gynecol Oncol 39(2):119–122
Leist M, Nicotera P (1997) The shape of death cell. Biochem Biophys Res Commun 236(1):1–9
Park MS, De Leon M, Devarajan P (2002) Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol JASN 13(4):858–865
Martelli L, Ragazzi E, Di Mario F, Basato M, Martelli M (2009) Cisplatin and oxaliplatin cytotoxic effects in sensitive and cisplatin-resistant human cervical tumor cells: time and mode of application dependency. Anticancer Res 29(10):3931–3937
Liao SK, Perng YP, Shen YC, Chung PJ, Chang YS, Wang CH (1998) Chromosomal abnormalities of a new nasopharyngeal carcinoma cell line (NPC-BM1) derived from a bone marrow metastatic lesion. Cancer Genet Cytogenet 103(1):52–58
Nilsson JR (2008) Cytotoxic effect of cisplatin on Tetrahymena. J Cell Sci 90:707–716
Masters RW (2000) Animal cell culture, trypan blue assay sop, 3rd edn. JB Lippincott, Philadelphia
Wang X, Wong SC, Pan J, Tsao SW, Fung KH, Kwong DL et al (1998) Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells. Can Res 58(22):5019–5022
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wardhani, L.K., Kentjono, W.A. & Romdhoni, A.C. Association Between Dose and Duration of Cisplatin Exposure with Cytotoxicity Effect on Nasopharyngeal Carcinoma Stem Cell. Indian J Otolaryngol Head Neck Surg 71 (Suppl 1), 373–377 (2019). https://doi.org/10.1007/s12070-018-1317-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-018-1317-4